Johnson & Johnson, a leading global healthcare company, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1886, the company has established itself as a pioneer in the pharmaceutical, medical devices, and consumer health sectors. With a diverse portfolio that includes renowned products such as Band-Aid, Tylenol, and Neutrogena, Johnson & Johnson is distinguished by its commitment to innovation and quality. The company has achieved significant milestones, including the development of groundbreaking medical technologies and vaccines. As a trusted name in healthcare, Johnson & Johnson holds a strong market position, consistently ranking among the top companies in the industry. Its dedication to improving global health outcomes underscores its reputation as a leader in the healthcare landscape.
How does Johnson And Johnson's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Johnson And Johnson's score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Johnson & Johnson reported total carbon emissions of approximately 7.03 billion kg CO2e, comprising 314,690,000 kg CO2e from Scope 1, 116,236,000 kg CO2e from Scope 2, and 6,597,133,000 kg CO2e from Scope 3 emissions. This reflects a commitment to reducing their carbon footprint significantly. Since 2016, Johnson & Johnson has achieved a 41% reduction in absolute Scope 1 and Scope 2 emissions, decreasing from 1,166,456,000 kg CO2e in 2016 to 683,188,000 kg CO2e in 2022. The company has set ambitious targets to further reduce its emissions: a 60% reduction in absolute Scope 1 and 2 GHG emissions by 2030 from a 2016 baseline, and a 20% reduction in absolute upstream Scope 3 emissions over the same period. Additionally, Johnson & Johnson aims for carbon neutrality in its operations by 2030, with a specific goal to reduce Scope 2 emissions to near zero by 2025. The company is also committed to ensuring that 80% of its suppliers have science-based targets by 2028. These initiatives are part of Johnson & Johnson's broader strategy to address climate change and align with global sustainability goals, demonstrating their leadership in the pharmaceutical and biotechnology sector.
Access structured emissions data, company-specific emission factors, and source documents
| 1990 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 308,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 751,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 00,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Johnson And Johnson's Scope 3 emissions, which decreased by 2% last year and increased significantly since 2011, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 72% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Johnson And Johnson has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


Common questions about Johnson And Johnson's sustainability data and climate commitments